Reduction of cutaneous atrophy

Details Reduction of cutaneous atrophy Reduction of cutaneous atrophy

1992-02-13

1993-10-19

Page, Thurman

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Cosmetic, antiperspirant, dentifrice

424443, 424444, 424445, 424447, 514922, 514557, 514887, A61K 700, A61K 3119

Patent

active

052543439

ABSTRACT:
The cutaneous atrophy associated with the use of steroids topically can be ameliorated using salts of certain .alpha.-hydroxyacids.

REFERENCES:
patent: 4105783 (1978-08-01), Yu et al.
patent: 4246261 (1981-01-01), Van Scott et al.
patent: 4363815 (1982-12-01), Yu et al.
patent: 4380549 (1983-04-01), Van Scott et al.
patent: 4485091 (1984-11-01), Fitton
patent: 4889847 (1989-12-01), Kligman et al.
patent: 4937068 (1990-06-01), Baral
patent: 5019569 (1991-05-01), Kligman et al.
Fitzpatrick et al, (eds) Dermatology in General Medicine, (1971) pp. 41-43, 147-149 and 175-181.
The Merck Index, 10th ed., (1983) pp. 768 and 1178 (compounds 5173 and 8065).
E. Van Scott et al., "Alpha Hydroxy Acids: Procedures for Use in Clinical Practice", CUTIS, 43, Mar. 1989, p. 222.
E. Van Scott et al, "Alpha hydroxyacids: therapeutic potentials", Canadian Journal of Dermatology, 1, No. 5, Nov./Dec. 1989, p. 108.

Affiliated with

Also associated with

Rating

Reduction of cutaneous atrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reduction of cutaneous atrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction of cutaneous atrophy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1350006